HCV-associated cryoglobulinemic vasculitis: triple/dual antiviral treatment and/or rituximab? Reply to the comment by Ignatova et al

被引:5
|
作者
Saadoun, David [1 ]
Cacoub, Patrice [1 ]
机构
[1] Univ Paris 06, Dept Med Interne & Immunol Clin, Ctr Natl Reference Malad Syst & Autoimmunes Rares, Grp Hosp Pitie Salpetriere,AP HP,DHU Inflammat, Paris, France
关键词
MIXED CRYOGLOBULINEMIA; DACLATASVIR; RIBAVIRIN; THERAPY;
D O I
10.1136/annrheumdis-2014-206022
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:E59 / E59
页数:1
相关论文
共 33 条
  • [1] HCV-associated cryoglobulinaemic vasculitis: triple/dual antiviral treatment and/or rituximab?
    Ignatova, Tatiana
    Chernova, Olga
    Novikov, Pavel
    Moiseev, Sergey
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 (09) : E58 - +
  • [2] Treatment with rituximab of cryoglobulinemic vasculitis, which persisted despite successful treatment of HCV with antiviral treatment
    Zuber, J-P
    Spertini, F.
    [J]. SWISS MEDICAL WEEKLY, 2008, 138 : 55S - 55S
  • [3] Monoclonal antibodies to B-lymphocytes (rituximab) in the treatment of HCV-associated severe cryoglobulinemic glomerulonephritis
    Milovanova, S. Y.
    Lopatkina, T. N.
    Kozlovskaya, L. V.
    Krasnova, T. N.
    [J]. TERAPEVTICHESKII ARKHIV, 2007, 79 (06): : 69 - 72
  • [4] Antiviral therapy for cryoglobulinemic neuropathy: comment on the article by Saadoun et al - Reply
    Saadoun, David
    Piette, Jean-Charles
    Cacoub, Patrice
    [J]. ARTHRITIS AND RHEUMATISM, 2007, 56 (08): : 2810 - 2811
  • [5] Rituximab treatment in children: comment on the review by Looney et al - Reply
    Looney, R. John
    [J]. ARTHRITIS AND RHEUMATISM, 2008, 58 (08): : 2583 - 2584
  • [6] Clinical outcome of HCV-associated cryoglobulinemic glomerulonephritis following treatment with direct acting antiviral agents: a case-based review
    Obrisca, Bogdan
    Jurubita, Roxana
    Sorohan, Bogdan
    Iliescu, Laura
    Baston, Catalin
    Bobeica, Raluca
    Andronesi, Andreea
    Leca, Nicolae
    Ismail, Gener
    [J]. CLINICAL RHEUMATOLOGY, 2019, 38 (12) : 3677 - 3687
  • [7] Clinical outcome of HCV-associated cryoglobulinemic glomerulonephritis following treatment with direct acting antiviral agents: a case-based review
    Bogdan Obrișcă
    Roxana Jurubiță
    Bogdan Sorohan
    Laura Iliescu
    Cătălin Baston
    Raluca Bobeică
    Andreea Andronesi
    Nicolae Leca
    Gener Ismail
    [J]. Clinical Rheumatology, 2019, 38 : 3677 - 3687
  • [8] The Successful Treatment of a Case of HCV-associated Cryoglobulinemic Glomerulonephritis with Rituximab, Direct-acting Antiviral Agents, Plasmapheresis and Long-term Steroid Despite Serologically Persistent Cryoglobulinemia
    Muro, Koji
    Toda, Naohiro
    Yamamoto, Shinya
    Yanagita, Motoko
    [J]. INTERNAL MEDICINE, 2021, 60 (04) : 583 - 589
  • [9] Comment on: Induction treatment of ANCA-associated vasculitis with a single dose of rituximab: reply
    Turner-Stokes, Tabitha
    Sandhu, Eleanor
    Pepper, Ruth J.
    Salama, Alan D.
    Burns, Aine
    Little, Mark A.
    [J]. RHEUMATOLOGY, 2015, 54 (02) : 373 - 374
  • [10] Rituximab for antineutrophil cytoplasmic antibody-associated vasculitis-not everything in the garden is rosy: comment on the article by Cortazar et al Reply
    Cortazar, Frank B.
    Niles, John L.
    [J]. ARTHRITIS & RHEUMATOLOGY, 2017, 69 (10) : 2095 - 2096